BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35743158)

  • 1. New Borane-Protected Derivatives of α-Aminophosphonous Acid as Anti-Osteosarcoma Agents: ADME Analysis and Molecular Modeling, In Vitro Studies on Anti-Cancer Activities, and NEP Inhibition as a Possible Mechanism of Anti-Proliferative Activity.
    Mizerska-Kowalska M; Sowa S; Donarska B; Płaziński W; Sławińska-Brych A; Tomasik A; Ziarkowska A; Łączkowski KZ; Zdzisińska B
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha Ketoglutarate Downregulates the Neutral Endopeptidase and Enhances the Growth Inhibitory Activity of Thiorphan in Highly Aggressive Osteosarcoma Cells.
    Mizerska-Kowalska M; Sławińska-Brych A; Niedziela E; Brodovskiy V; Zdzisińska B
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha Ketoglutarate Exerts In Vitro Anti-Osteosarcoma Effects through Inhibition of Cell Proliferation, Induction of Apoptosis via the JNK and Caspase 9-Dependent Mechanism, and Suppression of TGF-β and VEGF Production and Metastatic Potential of Cells.
    Kaławaj K; Sławińska-Brych A; Mizerska-Kowalska M; Żurek A; Bojarska-Junak A; Kandefer-Szerszeń M; Zdzisińska B
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nudol, a phenanthrene derivative from
    Zhang Y; Zhang Q; Xin W; Liu N; Zhang H
    Drug Des Devel Ther; 2019; 13():2591-2601. PubMed ID: 31551653
    [No Abstract]   [Full Text] [Related]  

  • 5. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin Inhibits Cell Migration and Invasion in Human Osteosarcoma Cells.
    Lan H; Hong W; Fan P; Qian D; Zhu J; Bai B
    Cell Physiol Biochem; 2017; 43(2):553-567. PubMed ID: 28965117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.
    Li Z; Liu H; Li B; Zhang Y; Piao C
    Cell Biochem Biophys; 2015 Jul; 72(3):719-26. PubMed ID: 25627547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D Represses the Aggressive Potential of Osteosarcoma.
    Tahbazlahafi B; Paknejad M; Khaghani S; Sadegh-Nejadi S; Khalili E
    Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1312-1318. PubMed ID: 32955002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
    Liu B; Xu L; Dai EN; Tian JX; Li JM
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.
    Long C; Chen J; Zhou H; Jiang T; Fang X; Hou D; Liu P; Duan H
    Cell Cycle; 2019 Feb; 18(3):346-358. PubMed ID: 30640578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral endopeptidase (NEP) inhibitors - thiorphan, sialorphin, and its derivatives exert anti-proliferative activity towards colorectal cancer cells in vitro.
    Mizerska-Kowalska M; Kreczko-Kurzawa J; Zdzisińska B; Czerwonka A; Sławińska-Brych A; Maćkiewicz Z; Nidzworski D; Kandefer-Szerszeń M
    Chem Biol Interact; 2019 Jul; 307():105-115. PubMed ID: 31054283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15d-PGJ
    Mikulčić M; Tabrizi-Wizsy NG; Bernhart EM; Asslaber M; Trummer C; Windischhofer W; Sattler W; Malle E; Hrzenjak A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non‑covalent proteasome inhibitor PI‑1840 induces apoptosis and autophagy in osteosarcoma cells.
    Chen Y; Chen H; Xie H; Yuan S; Gao C; Yu L; Bi Z
    Oncol Rep; 2019 May; 41(5):2803-2817. PubMed ID: 30864717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osthole Induces Cell Cycle Arrest and Inhibits Migration and Invasion via PTEN/Akt Pathways in Osteosarcoma.
    Wang L; Yang L; Lu Y; Chen Y; Liu T; Peng Y; Zhou Y; Cao Y; Bi Z; Liu T; Liu Z; Shan H
    Cell Physiol Biochem; 2016; 38(6):2173-82. PubMed ID: 27185245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis.
    Ji T; Lin C; Krill LS; Eskander R; Guo Y; Zi X; Hoang BH
    Mol Cancer; 2013 Jun; 12():55. PubMed ID: 23764122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ouabain Induces Apoptotic Cell Death Through Caspase- and Mitochondria-dependent Pathways in Human Osteosarcoma U-2 OS Cells.
    Chou WH; Liu KL; Shih YL; Chuang YY; Chou J; Lu HF; Jair HW; Lee MZ; Au MK; Chung JG
    Anticancer Res; 2018 Jan; 38(1):169-178. PubMed ID: 29277770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
    Mei L; Sang W; Cui K; Zhang Y; Chen F; Li X
    Cancer Sci; 2019 Feb; 110(2):582-595. PubMed ID: 30520540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capsaicin inhibits proliferation and induces apoptosis in osteosarcoma cell lines via the mitogen‑activated protein kinase pathway.
    Zhang Y; Deng X; Lei T; Yu C; Wang Y; Zhao G; Luo X; Tang K; Quan Z; Jiang D
    Oncol Rep; 2017 Nov; 38(5):2685-2696. PubMed ID: 29048662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
    Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
    Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.